240-year-old drug could save UK NHS £100 million a year treating common heart rhythm disorder

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure. This was compared to usual treatment with a beta-blocker according to a new study from the University of Birmingham, the city where digoxin was first used in 1785.

New study uncovers how gliomas disrupt brain function and points to rapid therapeutic reversal

A study led by Dr. Peter Canoll’s lab, in collaboration with researchers at Columbia University Irving Medical Center, Zuckerman Institute, and Irving Institute for Cancer Dynamics, along with multiple other researchers at other universities, provides novel insights into how gliomas—aggressive brain tumors—cause debilitating neurological symptoms such as seizures and cognitive impairments.

Cognitive abilities: Mapping the impact of DNA modifications

A significant advancement in knowledge of the link between cognition and genetics has been made thanks to a study led by Université de Montréal graduate students Guillaume Huguet and Thomas Renne, working under the supervision of medical geneticist Sébastien Jacquemont, an associate professor of pediatrics and a researcher at the UdeM-affiliated CHU Saint-Justine.